50 closest statements
by meaning · ranked by similarity · 100 per pageMeaning search returns the 50 nearest statements, then applies your filters.
“Our mission is to become a world-leading manufacturer of veterinary vaccines and to provide reliable veterinary vaccines to the world.”In use 2025 – now·1 sighting·SEC Form 20-F, filed 2025-07-0363% match
“Our mission is to keep pharmaceuticals secure from the manufacturer/distributor to the patient by delivering integrated solutions across the United States and Canada.”In use 2024 – now·1 sighting·SEC Form S-1/A, filed 2024-05-3159% match
“Our mission is to build a major ophthalmic pharmaceutical company.”In use 2015 – now·1 sighting·SEC Form 10-K, filed 2015-02-2758% match
“Our mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through our subsidiary MiNK Therapeutics, Inc. (“MiNK”)), and vaccine adjuvants (through our subsidiary SaponiQx, Inc. (“SaponiQx”)).”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-03-1457% match
“Our mission is to become the world leader in the sustainable manufacture of KLH and use our unique, proprietary methods and intellectual property to serve the growing demand for KLH in immunotherapeutic and immunodiagnostic markets.”In use 2015 – now·1 sighting·SEC Form 10-K, filed 2015-12-1457% match
“Our purpose is simple: Saving and improving lives with AI-Immunology™ powered vaccines.”In use 2026 – now·1 sighting·SEC Form 20-F, filed 2026-03-0557% match
“Our mission is to leverage our proprietary highly productive, and scalable microbial fungal protein production platforms to meet the growing demand for proteins in both human and animal health markets worldwide.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-03-2856% match
“Our mission is to build an ophthalmology-focused biopharmaceutical company that capitalizes on the gaps that we believe increasingly exist in the ophthalmology sector between single product companies and large, multi-product pharmaceutical companies.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-03-0656% match
“Our mission is to become a global leader in developing better and safer radioimmunotherapy and antibody-based oncology therapies addressing clear unmet medical needs and, as such, have a transformational impact on the lives of patients.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-03-0456% match
“Our mission is to alleviate the most human suffering possible by developing active immunotherapy product candidates that improve the quality of care for chronic diseases and are accessible to all patients across the globe.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-03-2755% match
“Our mission is to become the world’s leading provider of innovative products and combined solutions for agriculture and environmental health.”In use 2005 – now·1 sighting·SEC Form 20-F, filed 2005-03-1555% match
“Our mission is to be a leading global biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies that improve the lives of patients.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2654% match
“Our mission is to build a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2654% match
“Our mission is to build a world-class biopharmaceutical and biotechnology company, with a leading position in key therapeutic areas.”In use 2020 – now·1 sighting·SEC Form 20-F, filed 2020-03-1254% match
“Our mission is to be a leading provider of superior molecular solutions.”In use 2008 – now·1 sighting·SEC Form 10-K, filed 2008-03-0754% match
“Our mission is to be a global leader in generics, innovative medicines and biopharmaceuticals, improving the lives of patients.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-02-1254% match
“Our mission is to become a leader in high-barrier to entry generic pharmaceuticals.”In use 2021 – now·1 sighting·SEC Form 10-K, filed 2021-05-0454% match
“Our mission is to inspire advances in bioprocessing as a trusted partner in the production of biologic drugs that improve human health worldwide.”In use 2017 – now·1 sighting·SEC Form 10-K, filed 2017-02-2354% match
“The Company's mission is to expand the use of Kids Germ Defense products to improve and protect the health of kids nationwide.”In use 2009 – now·1 sighting·SEC Form S-1/A, filed 2009-11-2454% match
“Our mission is to become a leading global, fully integrated biopharmaceutical company engaged in discovering, developing and commercializing both first- and best-in-class therapies to address global unmet medical needs primarily in hematological malignancies.”In use 2025 – now·1 sighting·SEC Form 424B4, filed 2025-01-2454% match
“Our mission is to improve our clients’ participants’ health through the timely delivery of effective pharmaceutical care through our nationwide network of pharmacies and our own mail service and specialty pharmacies.”In use 2006 – now·1 sighting·SEC Form 10-K, filed 2006-09-1354% match
“Our mission is to become the leading worldwide provider of animal health products and services in the production animal and companion animal health products markets.”In use 2010 – now·1 sighting·SEC Form 10-K, filed 2010-09-1053% match
“Our mission is to provide access to high-quality, innovative, impactful, and affordable medicines to billions more people globally.”In use 2021 – now·1 sighting·SEC Form 10-K, filed 2021-02-2553% match
“Our mission is to use our immunotherapies and apply them to veterinary medicine.”In use 2019 – now·1 sighting·SEC Form 10-K, filed 2019-04-1653% match
“Our mission is to discover and develop effective biologic treatments for people with life-threatening conditions and to evolve Inhibrx into a commercial-stage biopharmaceutical company with a differentiated and sustainable product portfolio by focusing on the following:.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-02-2853% match
“Our mission is to build a fully integrated, commercial-stage biopharmaceutical company that develops important therapies for patients with unmet medical needs.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2553% match
“Our mission is to lead the field of Precision Immunotherapy® by aligning the interests of patients, employees and shareholders.”In use 2016 – now·1 sighting·SEC Form 10-K, filed 2016-03-1553% match
“Compugen’s mission is to be the world leader in the discovery and licensing of product candidates to the therapeutic and diagnostic industries under milestone and revenue sharing agreements.”In use 2010 – now·1 sighting·SEC Form 20-F, filed 2010-03-1153% match
“Our mission is to be the most sustainable producer and reliable supplier of consistent, high quality fresh shell eggs, egg products and prepared foods in the United States.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-07-2253% match
“Our mission is to improve the lives of patients throughout the world by successfully identifying, developing and commercializing innovative specialty biopharmaceutical products.”In use 2014 – now·1 sighting·SEC Form 10-K, filed 2014-02-2853% match
“Our mission is to become a world-leading manufacturer of medical devices, and we are committed to providing professional and reliable medical devices to the world.”In use 2026 – now·1 sighting·SEC Form 20-F, filed 2026-01-3053% match
“The Company's mission is to improve the quality of life of the 70 million people in North America and the 1.5 billion people worldwide who suffer from hearing impairment and/or hearing-related issues.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-09-1453% match
“Our mission is to build a breakthrough oncology company creating neoantigen-based therapies that significantly improve the lives of patients.”In use 2018 – now·1 sighting·SEC Form 424B4, filed 2018-06-2853% match
“Our mission is to bring off-the-shelf cellular immunotherapies with disease-transforming potential initially to patients with autoimmune diseases and cancer.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2653% match
“Our mission is to supply the highest quality New Age/Alternative Beverages and snack products at the most economical cost to distributors servicing the retail industry and directly to consumers through our website.”In use 2015 – now·1 sighting·SEC Form 10-K, filed 2015-06-2353% match
“Our mission is to advance humanity by engineering immunotherapies that are safer, more effective, and broadly accessible.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2653% match
“Our mission is to develop treatments for serious diseases.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-03-2253% match
“Our mission is to become a leading fully-integrated pharmaceutical company delivering new medicines to patients with unmet medical needs.”In use 2016 – now·1 sighting·SEC Form 10-K, filed 2016-03-2853% match
“Our mission is to expand our portfolio into a wide range of muscle diseases and become a leader in this area by advancing life-transforming therapeutics for patients with serious muscle diseases.”In use 2021 – now·1 sighting·SEC Form 10-K, filed 2021-03-0452% match
“Our mission is to drive energy resilience, industrial competitiveness, and supply chain security by leveraging robust, scalable biotechnology solutions to maximize the value of domestic resources.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-3152% match
“Our mission is to power as many impactful, high-performing and wholly organic solutions as possible through product lines and a series of licensing and distribution partnerships.”In use 2021 – now·1 sighting·SEC Form 10-K, filed 2021-04-1552% match
“Our mission is to develop a vaccine to prevent UTI infections and advance our anti -cancer and cystic fibrosis development compounds into humans.”In use 2024 – now·1 sighting·SEC Form S-1/A, filed 2024-06-1852% match
“Our mission is to be the leading global value-added and sustainable distributor of vehicle parts and accessories by offering our customers the most comprehensive, available and cost-effective selection of parts and service solutions while building strong partnerships with our employees and the communities in which we operate.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-1952% match
“Our mission is to be at the forefront of the fast-growing category of sublingual mouth strip as a method of delivering medication, homeopathic therapy, and other health and wellness products to the consumer.”In use 2016 – now·1 sighting·SEC Form S-1, filed 2016-02-1252% match
“Our mission is to solve unmet medical needs by commercializing discoveries from research universities and medical centers We are a biopharmaceutical company that seeks to bridge the “bench-to-bedside” gap between medical research discoveries and patient solutions.”In use 2022 – now·1 sighting·SEC Form S-1/A, filed 2022-04-1152% match
“Our mission is to become the leading company in precision genetic medicines by discovering, developing, manufacturing, and ultimately commercializing a new class of medicines through our proprietary base editing technology, with the goal of providing life-long cures to patients suffering from serious diseases.”In use 2020 – now·1 sighting·SEC Form 424B4, filed 2020-10-0152% match
“Our mission is to be a significant provider of quality products in the markets we serve.”In use 2013 – now·1 sighting·SEC Form 10-K, filed 2013-07-1152% match
“Our mission is to disarm dreaded viral diseases and create robust, modern biodefense countermeasures.”In use 2013 – now·1 sighting·SEC Form 10-K/A, filed 2013-05-1552% match
“Our mission is to create a new distribution model for agricultural inputs in Latin America, attracting, retaining and rewarding employees committed to providing extraordinary products and services to rural producers.”In use 2023 – now·1 sighting·SEC Form 20-F, filed 2023-11-0152% match
“Our mission is to meet the continually evolving threat of bacterial infections by discovering, developing and commercializing a continuous stream of novel antibiotics.”In use 2018 – now·1 sighting·SEC Form 10-K/A, filed 2018-04-3052% match
Showing 1–50 of 50